ELLIE MAE INC 4

4 · ELLIE MAE INC · Filed Feb 3, 2017

Form 4

Period: 2017-02-01

EVP, Finance & Admin, CFO

Transactions

Exercise/Conversion
Common Stock
2017-02-01$46.24/sh+700$32,368→ 45,389 total
Exercise/Conversion
Common Stock
2017-02-01$19.60/sh+200$3,920→ 44,889 total
Sale
Common Stock
2017-02-01$83.42/sh−200$16,685→ 44,689 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2017-02-01−200→ 2,100 total
Exercise: $19.60Exp: 2023-02-04→ Common Stock (200 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2017-02-01−750→ 8,500 total
Exercise: $24.93Exp: 2024-02-05→ Common Stock (750 underlying)
Sale
Common Stock
2017-02-01$83.42/sh−700$58,397→ 44,689 total
Exercise/Conversion
Common Stock
2017-02-01$24.93/sh+750$18,698→ 45,439 total
Sale
Common Stock
2017-02-01$83.42/sh−750$62,568→ 44,689 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2017-02-01−700→ 10,462 total
Exercise: $46.24Exp: 2025-02-11→ Common Stock (700 underlying)

Footnotes (6)

[F1]The exercise of these stock options was completed pursuant to the reporting person's Rule 10b5-1 trading plan.
[F2]The price reported is a weighted average price. The shares were sold in multiple transactions ranging from $83.0000 to $83.7100, inclusive. The reporting person undertakes to provide to Ellie Mae, Inc., any security holder of Ellie Mae, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
[F3]Option vests with respect to 25% of the shares subject thereto on February 4, 2014, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 4, 2017.
[F4]The reported transaction is a grant of a derivative security, in which we have left column 8 blank, and have reported the exercise or conversion price of the derivative security in column 2.
[F5]Option vests with respect to 25% of the shares subject thereto on February 5, 2015, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 5, 2018.
[F6]Option vests with respect to 25% of the shares subject thereto on February 11, 2016, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 11, 2019.

Documents

1 file